Literature DB >> 19214973

Splenectomy in hereditary spherocytosis: Review of 1,657 patients and application of the pediatric quality indicators.

Fizan Abdullah1, Yiyi Zhang, Melissa Camp, Mark I Rossberg, Melinda A Bathurst, Paul M Colombani, James F Casella, Rosemary Nabaweesi, David C Chang.   

Abstract

OBJECTIVE: The objective of the present study is to profile the outcome and safety of pediatric patients undergoing splenectomy with hereditary spherocytosis (HS) using a nationwide sample and the Agency for Healthcare Research and Quality (AHRQ) Pediatric Quality Indicators (PDIs). PATIENTS AND METHODS: A retrospective cross-sectional descriptive analysis of a non-overlapping combination of the National Inpatient Sample (NIS), and Kids' Inpatient Database (KID) databases (1988-2004) were performed. These combined databases contain information from nearly 93 million discharges in the United States. Children with an age at admission of <18 years of age and HS (ICD-9 diagnosis code of 282.0) who underwent total splenectomy (ICD-9 procedure code of 41.5) were identified. Variables of gender, race, co-existing diagnoses, hospital type, and charges adjusted to 2006 dollars, length of stay, inpatient mortality, and complications were collected. PDIs were identified for each patient by linking the data obtained from the NIS and KID databases with the PDIs using the AHRQ Quality Indicators Wizard.
RESULTS: Splenectomy for HS was associated with low morbidity and mortality. Accompanying cholecystectomy and/or appendectomy appeared to be safely performed at the same operation. Of the 13 PDIs identified by AHRQ as potentially avoidable adverse events, none were observed to occur in more than 1% of the patients.
CONCLUSIONS: Based on the results of this study, splenectomy in patients with HS appears safe and to result in a minimal number of potentially preventable complications as identified by the AHRQ PDIs. We have successfully demonstrated use of the indicators to aid in the analysis of a specific surgical procedure within a subset of the pediatric population. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19214973     DOI: 10.1002/pbc.21954

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

1.  Laparoscopic splenectomy in patients with hereditary spherocytosis: report on 12 consecutive cases.

Authors:  R Vecchio; Eva Intagliata; F Ferla; S Marchese; R R Cacciola; E Cacciola
Journal:  Updates Surg       Date:  2013-10-16

Review 2.  Hereditary red cell membrane defects: diagnostic and clinical aspects.

Authors:  Wilma Barcellini; Paola Bianchi; Elisa Fermo; Francesca G Imperiali; Anna P Marcello; Cristina Vercellati; Anna Zaninoni; Alberto Zanella
Journal:  Blood Transfus       Date:  2011-01-13       Impact factor: 3.443

3.  A systematic review of hereditary spherocytosis reported in Chinese biomedical journals from 1978 to 2013 and estimation of the prevalence of the disease using a disease model.

Authors:  Chao Wang; Yazhou Cui; Yan Li; Xiao Liu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2015-05

4.  Hereditary spherocytosis: evaluation of 68 children.

Authors:  Çapan Konca; Murat Söker; Mehmet Ali Taş; Ruken Yıldırım
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-11       Impact factor: 0.900

5.  Clinical course of 63 children with hereditary spherocytosis: a retrospective study.

Authors:  Maria Christina Lopes Araujo Oliveira; Rachel Aparecida Ferreira Fernandes; Carolina Lins Rodrigues; Daniela Aguiar Ribeiro; Maria Fernanda Giovanardi; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.